Navigation Links
Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
Date:1/25/2008

NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Assurant, Inc. ("Assurant") (NYSE: AIZ), a premier provider of specialty insurance and insurance-related products and services, announced today that its board of directors has declared a quarterly dividend of $0.12 per common share. The dividend will be payable on March 10, 2008 to shareholders of record as of Feb. 25, 2008.

Future dividend declarations will be made at the discretion of the board of directors and will be based on such factors as the company's earnings, financial condition, cash requirements, future prospects and other factors.

Assurant is a premier provider of specialized insurance products and related services in North America and selected international markets. Its four key businesses -- Assurant Solutions; Assurant Specialty Property; Assurant Health; and Assurant Employee Benefits -- have partnered with clients who are leaders in their industries and have built leadership positions in a number of specialty insurance market segments worldwide.

Assurant, a Fortune 500 company and a member of the S&P 500, is traded on the New York Stock Exchange under the symbol AIZ. Assurant has over $25 billion in assets and $7 billion in annual revenue. http://www.assurant.com


'/>"/>
SOURCE Assurant, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Assurant Health Gains Access to Great-West Healthcares Nationwide Network
2. MinuteClinic Becomes Participating Provider with Assurant Health
3. OPKO Health Announces Changes to Board of Directors
4. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
5. Carlson Executive Joins Blue Cross Board of Trustees
6. Consumer Group Criticizes NYC Board of Health Over Menu Labeling Bill
7. Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board
8. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
9. MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors
10. Digirad Corporation Board of Directors Appoints R. King Nelson Chairman
11. Vicky Goldberg Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: